A $10.5 million verdict awarded in an Accutane lawsuit over inflammatory bowel disease has been reversed by a New Jersey appeals court, which ruled that Roche was wrongly prohibited from introducing evidence to the jury about the number of individuals who have used the popular acne medication over the years. For more on the story go to
AboutLawsuits.com,
Drug and Device Law blog, and
Pharmalot.
No comments:
Post a Comment